These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128. The increasing mortality of idiopathic pulmonary fibrosis: fact or fallacy? Ryerson CJ; Kolb M Eur Respir J; 2018 Jan; 51(1):. PubMed ID: 29348187 [No Abstract] [Full Text] [Related]
129. ATF3 represses PINK1 gene transcription in lung epithelial cells to control mitochondrial homeostasis. Bueno M; Brands J; Voltz L; Fiedler K; Mays B; St Croix C; Sembrat J; Mallampalli RK; Rojas M; Mora AL Aging Cell; 2018 Apr; 17(2):. PubMed ID: 29363258 [TBL] [Abstract][Full Text] [Related]
130. Safer approaches to therapeutic modulation of TGF-β signaling for respiratory disease. Lachapelle P; Li M; Douglass J; Stewart A Pharmacol Ther; 2018 Jul; 187():98-113. PubMed ID: 29462659 [TBL] [Abstract][Full Text] [Related]
131. Physiology of the lung in idiopathic pulmonary fibrosis. Plantier L; Cazes A; Dinh-Xuan AT; Bancal C; Marchand-Adam S; Crestani B Eur Respir Rev; 2018 Mar; 27(147):. PubMed ID: 29367408 [TBL] [Abstract][Full Text] [Related]
133. German Guideline for Idiopathic Pulmonary Fibrosis - Update on Pharmacological Therapies 2017. Behr J; Günther A; Bonella F; Geißler K; Koschel D; Kreuter M; Prasse A; Schönfeld N; Sitter H; Müller-Quernheim J; Costabel U Pneumologie; 2018 Feb; 72(2):155-168. PubMed ID: 29341047 [TBL] [Abstract][Full Text] [Related]
134. R-Spondin-2 Is Upregulated in Idiopathic Pulmonary Fibrosis and Affects Fibroblast Behavior. Munguía-Reyes A; Balderas-Martínez YI; Becerril C; Checa M; Ramírez R; Ortiz B; Meléndez-Zajgla J; Pardo A; Selman M Am J Respir Cell Mol Biol; 2018 Jul; 59(1):65-76. PubMed ID: 29345973 [TBL] [Abstract][Full Text] [Related]
135. The unmet medical need of pulmonary hypertension in idiopathic pulmonary fibrosis. Cottin V; Price LC; Valenzuela C Eur Respir J; 2018 Jan; 51(1):. PubMed ID: 29348188 [No Abstract] [Full Text] [Related]
136. Treprostinil inhibits proliferation and extracellular matrix deposition by fibroblasts through cAMP activation. Lambers C; Roth M; Jaksch P; Muraközy G; Tamm M; Klepetko W; Ghanim B; Zhao F Sci Rep; 2018 Jan; 8(1):1087. PubMed ID: 29348469 [TBL] [Abstract][Full Text] [Related]
137. A Shared Pattern of β-Catenin Activation in Bronchopulmonary Dysplasia and Idiopathic Pulmonary Fibrosis. Sucre JMS; Deutsch GH; Jetter CS; Ambalavanan N; Benjamin JT; Gleaves LA; Millis BA; Young LR; Blackwell TS; Kropski JA; Guttentag SH Am J Pathol; 2018 Apr; 188(4):853-862. PubMed ID: 29355514 [TBL] [Abstract][Full Text] [Related]
138. The pronounced high expression of discoidin domain receptor 2 in human interstitial lung diseases. Bian H; Nie X; Bu X; Tian F; Yao L; Chen J; Su J ERJ Open Res; 2018 Jan; 4(1):. PubMed ID: 29367920 [TBL] [Abstract][Full Text] [Related]
139. Potential Mechanisms Underlying TGF-β-mediated Complement Activation in Lung Fibrosis. Fisher AJ; Cipolla E; Varre A; Gu H; Mickler EA; Vittal R Cell Mol Med Open Access; 2017; 3(3):. PubMed ID: 29377033 [TBL] [Abstract][Full Text] [Related]
140. Improvement of hepatic fibrosis and patient-reported outcomes in non-alcoholic steatohepatitis treated with selonsertib. Younossi ZM; Stepanova M; Lawitz E; Charlton M; Loomba R; Myers RP; Subramanian M; McHutchison JG; Goodman Z Liver Int; 2018 Oct; 38(10):1849-1859. PubMed ID: 29377462 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]